Literature DB >> 19232874

Severe non-anion gap metabolic acidosis induced by topiramate: a case report.

Joseph R Shiber1.   

Abstract

BACKGROUND: A non-anion gap acidosis can be induced by topiramate, causing symptomatic dyspnea and confusion.
OBJECTIVES: Discuss the pathophysiology of the hyperchloremic metabolic acidosis caused by topiramate, the typical clinical presentation, and the recommended treatment. CASE REPORT: This case presents a young woman with a clinically significant non-anion gap metabolic acidosis believed to be caused by topiramate. She had been taking the medication for several months without prior adverse effects. Once she began having dyspnea as a respiratory response to the renal tubule acidosis, she had decreased oral intake of food and fluids, which induced a pre-renal acute renal failure that worsened her acidemia. In the Emergency Department, she received intravenous fluids and sodium bicarbonate, and later was intubated for mechanical ventilation due to respiratory fatigue. With the topiramate withdrawn, the patient had a full recovery of her renal function and metabolic acid-base status over the next 72 h. This case serves to increase awareness of this possible adverse effect and the recommended treatment as topiramate becomes more widely used.
CONCLUSIONS: Topiramate can induce a renal tubule acidosis resulting in a hyperchloremic metabolic acidosis. Recognition of the underlying cause is crucial so that the drug can be withdrawn while supportive care is provided. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19232874     DOI: 10.1016/j.jemermed.2008.11.017

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  4 in total

Review 1.  Pharmacologically-induced metabolic acidosis: a review.

Authors:  George Liamis; Haralampos J Milionis; Moses Elisaf
Journal:  Drug Saf       Date:  2010-05-01       Impact factor: 5.606

Review 2.  Metabolic disturbances and renal stone promotion on treatment with topiramate: a systematic review.

Authors:  Valentina G Dell'Orto; Eva A Belotti; Barbara Goeggel-Simonetti; Giacomo D Simonetti; Gian Paolo Ramelli; Mario G Bianchetti; Sebastiano A G Lava
Journal:  Br J Clin Pharmacol       Date:  2014-06       Impact factor: 4.335

3.  Early Post-operative Hemodynamic Perturbation Associated with Topiramate-induced Metabolic Acidosis: A Case Report.

Authors:  Shalendra Singh; Sujoy Banik; Keshav Goyal; Surya Kumar Dube
Journal:  J Pediatr Neurosci       Date:  2018 Apr-Jun

Review 4.  Mitochondrial disorders and drugs: what every physician should know.

Authors:  Daniele Orsucci; Elena Caldarazzo Ienco; Gabriele Siciliano; Michelangelo Mancuso
Journal:  Drugs Context       Date:  2019-07-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.